UK-wide COVID-19 vaccine study reports long-term third dose booster protection
Third dose COVID-19 booster vaccines offer lasting protection after several months, according to the latest results of a nationwide...
top of page
Latest news
- Oct 7, 2022
New research explores COVID-19 risk in South African children
Southampton researchers are to bring new insight into COVID-19 risk factors for children in South Africa. Most research during the...
- Sep 6, 2022
New study uses lessons of COVID-19 to develop new treatments for severe viral infection
Southampton researchers are looking to improve the prevention and treatment of lung and airway infections. They plan to do this using the...
- Sep 1, 2022
Mental health issues in teenage girls rose during the pandemic
The number of teenage girls attending emergency departments with mental health issues rose during the COVID-19 pandemic. New Southampton...
- Jul 28, 2022
COVID-19 vaccine study calls on pregnant women to help build booster dose guidance
Pregnant women in the south are being invited to help discover the most effective use of booster vaccines during pregnancy. The Preg-CoV...
- Jun 15, 2022
COVID-19 study supports flexible intervals between Pfizer and Oxford/AstraZeneca vaccine doses
Southampton researchers have helped show a greater immune response occurs if two doses of the Pfizer-BioNTech or Oxford-AstraZeneca...
- Jun 6, 2022
Southampton professor receives OBE in Queen’s Jubilee Honours for COVID-19 vaccine research
Professor Saul Faust has been awarded an OBE in the Queen’s Jubilee Honours List. The Consultant Paediatrician at University Hospital...
- May 30, 2022
Com-COV vaccine study to analyse third dose options for 12 to 15 year olds
Researchers in Southampton have launched a new study of COVID-19 vaccine schedules in young people. Comparing different boosters and doses...
- May 27, 2022
COVID-19 vaccine after infection reduces risk of Long Covid
A new study involving Southampton’s Dr Nisreen Alwan suggests vaccination could help people with Long Covid. There is evidence that shows...
- May 13, 2022
Fourth COVID-19 vaccine dose provides strong immunity boost, shows UK study
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a...
- Mar 7, 2022
Southampton personal respirator approved for use beyond pandemic
Protective personal respirator hoods developed in Southampton have received UK approval for use beyond the COVID-19 pandemic. The PeRSo...
- Feb 10, 2022
Southampton expertise bolsters world-first deliberate COVID-19 infection trial
Researchers in Southampton are part of a world-leading ‘challenge’ trial that infected young, healthy volunteers to give unique insights...
- Feb 8, 2022
Saliva-based COVID-19 tests display high accuracy with and without symptoms
A clinical evaluation of a simplified processing method for a rapid COVID-19 test has shown high accuracy in people with and without...
- Feb 3, 2022
Southampton-led trial informs global booster guidance
The World Health Organisation (WHO) has used data from the COV-Boost trial in its advice on COVID-19 vaccine schedules. Comparing booster...
- Feb 3, 2022
Study reveals parents’ premature birth experiences during pandemic
Southampton research has shown that absence of birth partner, impact of face masks on bonding, and infection risk were key concerns for...
- Jan 24, 2022
Lower COVID-19 vaccine booster dose study launches in Southampton
Volunteers from Southampton and the surrounding area are set to receive a third lower COVID-19 vaccine booster dose through the COV-BOOST...
- Jan 19, 2022
Children with weakened immune systems not at higher risk from COVID-19
A year-long study led by Southampton researchers has shown children with a weakened immune system are not more likely to become seriously...
- Dec 29, 2021
Counting long-COVID: an interview with Dr Nisreen Alwan
Having contracted COVID-19 is early 2020, and unable to shake off symptoms, Dr Nisreen Alwan found her interest in long-COVID becoming...
- Dec 21, 2021
World’s first plant-based COVID-19 vaccine shares positive results
A Southampton-led UK study into the world's first plant-based COVID-19 vaccine has found it is 75% effective against the Delta variant....
- Dec 16, 2021
Long-COVID patients treated in hospital show limited recovery after one year
People treated in hospital with COVID-19 who remained unwell at five months show limited further recovery after one year, according to...
bottom of page